Last, one last RCT (Lobello et al. 2010) reported an increase in the occurrence of increased alkaline phosphatase, sweating, and insomnia in CYP2D6 poor metabolizers (PM) compared to extensive metabolizers (EMs). This evidence concerns the gene CYP2D6 and insomnia.